Isofol Medical

Isofol Medical AB is a biotechnology company dedicated to developing the anticancer drug Arfolitixorin, primarily for the treatment of advanced colorectal cancer, as well as a rescue drug following high-dose methotrexate treatment for osteosarcoma (bone cancer). Other potential uses of Arfolitixorin include the treatment of pancreatic cancer, breast cancer, gastric cancer, and head and neck cancer.